severe asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of severe asthma based on the criteria of the American Thoracic Society Age above 18 years Plan to undergo BT Ability to provide informed consent
Exclusion criteria
Exclusion criteria: asthma exacerbation during the prior month oral corticosteroid use greater than 30 mg/day use of immunosuppressants respiratory diseases such as emphysema use of beta-adrenergic blocking agents use of anticoagulants previous BT treatment any issue which in the opinion of the investigator might interfere with participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the relationships between the fluctuation of the biomarker(s) and response to BT defined by improvement in asthma quality of life | — |
Countries
Japan
Contacts
National Hospital Organization Tokyo National Hospital Clinical Research Center